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Abstract
Many peptides, when released as chemical messengers within the brain, have powerful influences
on complex behaviours. Most strikingly, vasopressin and oxytocin, once thought of as circulating
hormones whose actions were confined to peripheral organs, are now known to be released in the
brain where they play fundamentally important roles in social behaviours1. In humans, disruptions
of these peptide systems have been linked to several neurobehavioural disorders, including Prader-
Willi syndrome, affective disorders, and obsessive-compulsive disorder, and polymorphisms of
the vasopressin V1a receptor have been linked to autism2,3. Here we report that the rat olfactory
bulb contains a large population of interneurones which express vasopressin, that blocking the
actions of vasopressin in the olfactory bulb impairs the social recognition abilities of rats, and that
vasopressin agonists and antagonists can modulate the processing of information by olfactory bulb
neurones. The findings indicate that social information is processed in part by a vasopressin
system intrinsic to the olfactory system.
Complex social behaviour often depends on individual recognition, and most mammals
distinguish individuals by their olfactory signatures. Some individuals are accorded a
particular status, such as when a bond is formed between a mother and offspring, or between
sexual partners in monogamous species. In these cases, an olfactory memory is forged in the
olfactory bulb, partly as a result of the actions of peptides4. For example, oxytocin released
in the mother's brain during parturition helps to establish the olfactory signatures of the
offspring as memorable5.
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The converse of social attachment is rejection of, or aggression towards, individuals who are
recognised as intruders or competitors6. For this, vasopressin, a peptide closely related to
oxytocin, is important via its actions at V1 receptors, and mice without a functional
accessory olfactory system display many of the same behavioural deficits as mice that lack
V1 receptors. This suggests that vasopressin is involved in the processing and/or integration
of olfactory stimuli, and that it couples socially relevant olfactory cues with an appropriate
behavioural response7.
Here, we have identified a hitherto unreported population of vasopressin neurones in the
olfactory bulb (Fig.1). We first saw these cells in a transgenic rat line in which enhanced
green fluorescent protein (eGFP) was targeted to the vasopressin secretory pathway,
resulting in its co-packaging with vasopressin in secretory vesicles8. The main olfactory
bulb contains similar numbers of eGFP-expressing cells in males and females (99±14 and
103±10 cells/section; n=16,16), giving an estimated 5,000-7,000 neurones per bulb; the
accessory bulbs contained ~1,000 neurones. These large ovoid neurones (~15μm diameter)
are mostly located in the external plexiform layer close to the glomeruli (the structures in the
bulb that directly receive inputs from olfactory receptor cells). Each has several large
dendrites, one of which penetrates a single glomerulus where it gives rise to many small
branches, suggesting that they receive direct inputs from olfactory nerve afferents. Other
dendrites travel laterally to the external zones around neighbouring glomeruli (Fig.1b). By
immunocytochemistry, we showed that these cells indeed synthesise vasopressin (Fig.1d),
and we confirmed their presence in wild-type rats (Fig.1e). We also confirmed that they
express vasopressin mRNA by in situ hybridisation (Fig.1f), and that vasopressin is released
from olfactory bulb explants in vitro in response to depolarisation with high K+ (release
increased from 0.65±0.19 to 4.88±1.88pg/sample, P<0.01, n=9). The total bulb vasopressin
content was 42.9±2.6 pg/mg wet weight (n=12, mixed sex).
Unlike periglomerular cells and short axon cells (two other cell populations in the same
region) the vasopressin cells are immuno-negative for GABA, calretinin and calbindin-
D-28K9 (Fig.1g-i), but like external tufted (ET) cells9,10 they are immunoreactive for
glutamate (Fig.1j-l). No cells were immunoreactive for oxytocin. Whole-cell patch-clamp
recordings from olfactory bulb slices showed that the vasopressin cells have
electrophysiological characteristics like those of ET cells10. They show spontaneous bursts
of action potentials (1.5 bursts/s) arising at the start of a slow depolarising potential
envelope (6.5±0.5mV; n=5) from a resting membrane potential of -55±2mV, and have an
input resistance of 189±38MΩ. This bursting is voltage-dependent (Fig.1s), and injection of
depolarising current converts bursts of action potentials to an irregular firing pattern.
Unlike most ET cells, most vasopressin cells do not project outside the olfactory bulb.
Microinjections of the retrograde tracer fluorogold into the cortical amygdala, the piriform
cortex or olfactory tubercle (major projection sites of olfactory bulb efferents11) resulted in
labelling of most mitral cells (the main output neurones), but no vasopressin cells (Fig.1m-
o), injections into the anterior olfactory nucleus produced a very small number of labelled
cells (not shown). If the vasopressin cells do not project outside the olfactory bulb, any
effects of the vasopressin that they release on olfactory information flow must be reflected
by changes in the activity of other output cells. Vasopressin may be released from their axon
terminals, but the dendrites may be a more important source as these are densely filled with
vasopressin, and in the hypothalamus, vasopressin is released from dendrites in both an
activity-dependent manner and in an activity-independent way by agents that mobilise
intracellular calcium12.
Vasopressin receptors are widespread in the main and accessory olfactory bulbs13. We
found no immunoreactivity for V1a receptors on vasopressin cells, but some for V1b
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receptors (Fig.1p-r), so vasopressin may act as an autocrine regulator through this receptor
subtype14. Many other cells in the periglomerular region were immunoreactive for both
subtypes, as were mitral cells in the main and accessory bulb.
We tested the hypothesis that olfactory bulb vasopressin is involved in social recognition. It
has already been shown that infusion of vasopressin into the bulb can enhance social
recognition in rats. In those experiments, a peptide V1 antagonist had no significant effect.
15 Here, we used a non-peptide V1 antagonist (OPC 21268) that diffuses more readily, and
which is effective in antagonising the actions of dendritically released vasopressin in the
hypothalamus16. We injected the antagonist bilaterally into the olfactory bulb and tested
social discrimination17. In this test, a juvenile rat is placed in the home cage of an adult
male, and the time that the adult spends investigating it is measured. Later, the same juvenile
and an unfamiliar juvenile are introduced into the cage. Normally, the adult investigates the
familiar juvenile only briefly, and pays most attention to the unfamiliar juvenile; this
memory is short lasting (<40min) and is based on olfactory characteristics. In these
experiments, the adults were given a microinjection of the antagonist just before the juvenile
was first presented. When retested, the adults did not discriminate between the familiar and
unfamiliar juveniles, indicating no memory of the juvenile (F(3,39)=3.34, P =0.026; Fig.
2a,b).
To specifically test involvement of the V1a receptor subtype, we used infusions of a small
interference RNA (siRNA) targeted against V1a receptor mRNA (siRNA has been
previously used to successfully silence gene expression, including silencing the V2 receptor
in mouse kidney18); these infusions produced transfection in the olfactory bulb but not in
the septum (supplementary Fig.1). The effects of siRNA treatment were similar to those
obtained with antagonist (treatment: F(1,16)=17.86, P<0.01; factor interaction:
F(3,48)=4.37, P<0.01, Fig.2c). Control rats (but not siRNA-treated rats) could recognize
juveniles by their complex individual olfactory fingerprint even in the presence of
distracting mono-molecular odours (supplementary Fig.2a). Treatment with siRNA impaired
habituation/dishabituation to juvenile cues (control: F(4,32)=3.42, P<0.02; siRNA:
F(4,32)=0.47, P=0.76), but not to volatile odours (control: F(4,32)=5.672, P<0.01; siRNA:
F(4,32)=4.09, P<0.01) or object recognition (Fig.3a-c), and did not affect open field
behaviour (supplementary Fig.2b,c).
We also used a transgenic rat line in which the human diphtheria receptor is inserted into the
vasopressin promoter region. In these rats, infusion of diphtheria toxin19,20 results in a
local, selective destruction of vasopressin cells. Transgenic rats pretreated with toxin
infusions into the olfactory bulb showed a similar impairment of juvenile recognition
(treatment: F(1,29)=14.95, P<0.01; factor interaction: F(1,29)=4.99, P=0.033, Fig.2d), again
with no impairment of object recognition (Fig.3c), locomotor activity or anxiety-related
behaviours (supplementary Fig.2d-i).
Finally, we investigated vasopressin-dependent changes in olfactory bulb output. Current
theories of glomerular function propose that olfactory nerve afferents activate ET cells,
which activate short axon cells and periglomerular interneurones of the same glomerulus.
This amplifies the olfactory nerve input and imposes on it a bursting pattern10, and this
signal is transmitted to mitral cells. We recorded, in freely-breathing anaesthetised rats, from
mitral cells antidromically identified by electrical stimulation of the lateral olfactory tract
(Fig.4a,b and supplementary Fig.3). Under urethane anaesthesia, most mitral cells display
patterned discharge comprising prolonged intermittent bursts of action potentials21 (burst
duration 159±10s; interburst time 97±13 s, intraburst firing rate 6.4±0.5 Hz; n=94;
supplementary Fig. 3). Within these bursts, the firing activity is modulated by the respiratory
rhythm. In addition, many mitral cells (57/94) display a bimodal interspike interval
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distribution, reflecting the frequent occurrence of spike doublets within bursts. Thus, within
bursts, these cells fire at two distinct instantaneous frequencies; at 100-250 Hz (doublets;
mean modal interspike interval 3.2±0.4 ms), and at ~50 Hz (mode 18±1 ms). The doublets
are noteworthy as it is believed that only high frequency firing episodes are back-propagated
into the distal dendrites22. Topical administration of vasopressin or the V1 antagonist onto
the exposed bulb dorsal to the recording site modified the electrical activity of mitral cells.
Vasopressin reduced the proportion of time they were active, and particularly reduced
doublet firing, whereas the antagonist had the opposite effect (P<0.05, paired t-tests; Fig.4c-
e). In sixteen experiments, each involving a long recording from an identified mitral cell, we
identified an odour to which that cell was particularly responsive, established the
repeatability of that response in basal conditions, and then retested the response to
stimulation after topical application of vasopressin. In every case the response to the odour
was suppressed after vasopressin, whereas topical application of aCSF had no effect on the
responses of seven cells tested (Fig.4f-j).
These findings suggest that vasopressin is a retrograde signal that filters activation of the
mitral cells. Its effects may involve presynaptic modulation of noradrenaline or
acetylcholine release, both of which are increased by retrodialysis of vasopressin in the
olfactory bulb of ewes23. Because this filtering is important for social recognition, it seems
that the vasopressin release must depend on previous olfactory experience. In the
hypothalamus, activity-dependent dendritic vasopressin release can be conditionally
regulated (‘primed’) by recent experience12,24; such a mechanism in the olfactory bulb may
thus mediate conditional changes in olfactory recognition.
Thus the olfactory bulb contains vasopressin cells that process olfactory signals relevant to
social discrimination, and dendritic vasopressin release may be involved in filtering out
familiar signals. Genetic variations in brain vasopressin signalling are associated with
differences in social behaviours in humans25,26 as well as in animal models. We are not
suggesting that social recognition in humans depends on olfactory signals; vasopressin
affects social behaviour at many other sites as well as the olfactory bulb27,28, and in
humans olfactory recognition probably has only a small role. However, these studies suggest
a mechanism by which experience-dependent vasopressin release can facilitate social
recognition, and this mechanism may be common to several sites of action.
Methods summary
Animal experimental procedures were conducted with regulatory approval and ethics
committee approvals in the UK, Germany and Japan.
Brains were processed immunocytochemically to detect cells expressing vasopressin GFP;
calbindin D-28K calretinin; GABA; glutamate; and V1a receptors, and by in situ
hybridization to detect vasopressin mRNA and eGFP mRNA. Eleven eGFP rats were
stereotaxically microinjected with the retrograde tracer Fluorogold at various sites to detect
cells projecting from the olfactory bulb. Vasopressin content and potassium stimulated
release from olfactory bulb explants was measured by RIA.
To test effects on social discrimination, the V1 antagonist or vehicle was infused bilaterally
into the olfactory bulbs of adult rats15. A juvenile was introduced into the adult's cage for
4min, and the duration of investigation by the adult recorded; 30min (or 180min) later, the
juvenile was re-introduced with another unfamiliar juvenile, and the preference index was
measured17 (time investigating unfamiliar/(time investigating familiar + time investigating
unfamiliar juvenile)*100). Olfactory habituation and dishabituation29 was tested by
exposing rats to four 1-min trials separated by 10-min. During a fifth dishabituation trial the
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rats were exposed to a novel stimulus. In rats injected with siRNA directed against V1a
receptors (or control vectors), behaviours were tested 4, 8 and 16 days after injection.
For conditional ablation of vasopressin neurones, we used transgenic rats with a mutated
human heparin-binding epidermal growth factor–like growth factor (hHB-EGF)30 gene
under the control of vasopressin promoter. Diphtheria toxin was microinjected into the
olfactory bulb in rats anesthetized with tribromoethanol.
In urethane-anaesthetised rats, electrical activity of mitral cells was recorded before and
after administration of vasopressin or V1 antagonist onto a small exposure of the bulb. Cells
were tested with odours applied for 2s in an airstream directed at the nose. For in vitro
electrophysiology, whole-cell current-clamp recordings were made from GFP-expressing
cells in 300μm horizontal olfactory bulb slices.
Methods
Immunohistochemistry
Brains of eGFP and wild-type Sprague-Dawley rats were perfusion fixed with 4%
paraformaldehyde, post-fixed and cryoprotected31. Free-floating frozen bulb sections
(52μm) were immunostained with primary antibodies (ABs) (see supplementary table) for
24-48h at 4°C. Immunoreactivity was visualised with either biotinylated secondary ABs and
Alexa fluorophore conjugated streptavidin or Alexa fluorophore conjugated secondary ABs,
at 1:500 for 2h at room temperature. Sections were imaged as previously31.
In situ hybridisation
Six adult Wistar rats were decapitated under deep isoflurane anaesthesia. Brains were frozen
at −40°C in methylbutane and stored at −80°C. Cryosections (16μm) were thaw-mounted on
RNA-free slides and stored at −80°C. In situ hybridization was performed on sagittal
sections using [35S]-UTP-labelled ribonucleotide probes32. The pcDNA3 plasmid,
containing vasopressin precursor cDNA (595bp insert), was linearized with XbaI; the
pBluescript KS plasmid, containing the vasopressin specific 3′ end (230bp insert) was
linearized with HindIII. Both were in vitro transcribed with T7 RNA Polymerase to yield an
antisense cRNA probe. To generate an eGFP specific riboprobe, the cDNA encoding GFP
was subcloned into pBluescript SK. The eGFP fragment of peGFP-N3 (Clontech, Palo Alto,
CA) was isolated using the BamHI and NotI sites and subcloned via the same sites into
pBluescript SK. The construct was verified by sequencing. For the eGFP riboprobe, this
plasmid was linearized with BamHI and in vitro transcribed with T3 polymerase. Specific
activity of probes was ~108 cpm/μg. Radioactivity was adjusted to 3,3×106 cpm/100μl
hybridization buffer. Slides were dipped in Kodak NTB emulsion (Eastman Kodak,
Rochester, NY) diluted 1:1 with 0.5% glycerol and exposed for 6 days at 4°C, developed
and counterstained32.
Vasopressin release
Sprague-Dawley rats (100-200g) were decapitated and one half of an olfactory bulb was
incubated in oxygenated aCSF. 50mM K+ was applied for 5min and vasopressin measured
in 5-min samples. The other half was sonicated (5×4s), centrifuged (10.000g, 5min) and
vasopressin content determined in the supernatant by radioimmunoassay (sensitivity 0.1pg,
cross-reactivity to related peptides including oxytocin <0.7%, intra- and inter-assay
variability 6-9%).
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Antagonist, siRNA and diphtheria toxin injection and behaviour studies
The V1 antagonist33 (60ng in 3μl aCSF, OPC 21268, Otsuka America Phamaceutical Inc.,
Rockville, MD) or aCSF was infused under brief isoflurane anaesthesia over 2min through
bilateral guide cannulae (7mm anterior to bregma, 1.3mm lateral, 3mm deep, implanted 5
days before) as previously15. Rats received both vehicle and antagonist in a balanced
crossover design. For object recognition tests34 rats were exposed to a 500ml lab glass
bottle (Schott, Mainz, Germany) or a tube rack (W. Krannich GmbH, Göttingen, Germany)
for 4min. This was removed and 30min later was re-introduced for 4min with the other
object (the preference index was calculated as above). For volatile scent habituation, a
stainless steel tea egg (50 × 35mm) hanging from the top of the cage and containing filter
paper soaked with 5μl carvone ((R)-(−)-carvone diluted 1:100 in diethylphtalat; Merck,
Ismaning, Germany) was presented in trials 1-4. For dishabituation, the filter paper was
soaked with 5μl carvone mixed with isoamylacetate. For juvenile habituation, the same
juvenile was presented during trials 1-4 and a novel juvenile was used during the
dishabituation test. All behaviours were measured by experimenters blind to identity of
treatment.
Social discrimination with an additional scent was tested by scenting the juvenile with
carvone (5μl; (R)-(−)-carvone diluted 1:100 in diethylphtalat; Merck, Ismaning, Germany)
during the first session, and with isoamylacetate (5μl, Sigma-Aldrich, Taufkirchen,
Germany; diluted 1:100 in diethylphtalat) in the second session; the novel juvenile was
scented with carvone. Open field behaviour was tested in two different laboratories using
different equipment. In both cases the rats were naïve to the apparatus and the exposure
duration was 10min; exposure started by placing the rat in one corner of the apparatus.
Behaviour was recorded with a video camera mounted over the open field and behaviour
was scored. Rats (Sprague Dawley) that received the siRNA were placed in an open field
apparatus (100×100×50cm) 19 days after treatment. Locomotor activity was scored by
counting the number of crossed lines on a grid (10×10cm) on the floor of the open field.
Anxiety-related behaviour was monitored by measuring the duration the rat spent within the
centre area (80×80cm), expressed as % of the total duration of the open field testing.
Transgenic rats (Lewis rats with a mutated human heparin-binding epidermal growth factor-
like growth factor (hHB-EGF) gene under the control of vasopressin promoter, see below)
were tested 15-18 days after treatment with diphtheria toxin in an open-field apparatus
measuring 60×60×40cm. The total distance travelled and the time spent in the centre area
(40×40cm) were recorded. The time spent in the centre area was expressed as % of the total
duration of testing. Transgenic rats were tested 16-19 days after treatment with diphtheria
toxin in the elevated plus maze. The apparatus had two open (50×10cm) and two enclosed
arms of the same size with 40cm-high transparent walls (O'Hara & Co, Tokyo, Japan). The
arms and central square were constructed of black plastic and elevated to 65cm. The rat was
placed on the central platform with its head facing a closed arm. Entries into open arms,
time spent in open arms and locomotor activity were measured the public domain NIH
Image program (http://rsb.info.nih.gov/nih-image/) and Image J program (http://
rsb.info.nih.gov/ij/). (O'Hara & Co.)35.
siRNA treatment
The purified SMARTvector™ siRNA lentiviral particles targeting the rat vasopressin V1a
receptor (No. NM053019; No. SH-092092-02-10) and SMARTvector™ empty vector
control particles (No. S-004000-01) were from Thermo Fisher Scientific (Lafayette, CO,
USA). The titer of all solutions was >108 transforming Units/ml. Lentiviral solution (2μl)
was infused via a fused silica capillary into each olfactory bulb. Behaviour was tested 4, 8
and 16 days later.
Tobin et al. Page 6









To confirm transfection by the SMARTvector™ lentiviral particles, the TurboGFP reporter
protein was visualised immunohistochemically at 20 days after injection. Rats were
anaesthetised using a mixture of 0.1ml/ 0.06ml Ketavet and Dormitor (Pharmacia GmbH,
Erlangen; Bayer Vital GmbH, Leverkusen, respectively, Germany) and transcardially
perfused with physiological saline for 2min followed by 4% formaldehyde diluted in 0.1M
phosphate buffer pH7.4 (PB). Brains were postfixed for 20h in 4% formaldehyde diluted in
PB, transferred to 0.5M sucrose in PB for 6h and to 1M sucrose in PB for ~ 40h. Brains
were shock-frozen in isopentanol at −50 °C and stored at −80 °C until cryo-sectioning.
Floating frontal sections (25μm) were incubated with anti-TurboGFP antibody (evrogen,
Moscow, Russia, Cat # AB511, dilution 1:10000). Immunoreactive cells were visualised
using the ABC-method using Axiovision software (Zeiss, Jena, Germany) and
counterstained with Nissl staining. Immonostaining was observed in cells that surrounded
the track of the injection cannula (not shown) and in cells and fibers in the glomerular,
epiform plexus and mitral cell layers of the bulb.
Conditional ablation of vasopressin neurones
We used transgenic Lewis rats with a mutated human hHB-EGF gene under the control of
vasopressin promoter36. The hHB-EGF mutant has a high affinity to diphtheria toxin but no
EGF–like activity30. Diphtheria toxin binds to the extracellular domain of HB-EGF, is
incorporated into cells by receptor-mediated endocytosis, inactivates eukaryotic elongation
factor 2 through ADP-ribosylation, and thereby inhibits protein synthesis leading to cell
death19. Diphtheria toxin (D0564, Sigma, 300pg/3μl) was microinjected bilaterally into the
bulb of transgenic or wild-type rats anaesthetized with tribromoethanol (200mg/kg i.p.).
Transgenic rats injected i.c.v. with the toxin showed polyuria consistent with diabetes
insipidus, but no polyuria was seen in rats after intrabulbar injections, indicating no
significant loss of hypothalamic vasopressin cells (data not shown).
Retrograde tracing
eGFP rats were stereotaxically microinjected under Hypnorm-Hypnovel anaesthesia
(Pharmaceuticals, Oxford, UK) with Fluorogold (1μl, 1%, Lumafluor Inc, New City, NY,
USA) into the cortical amygdala (−2.1mm posterior to bregma; 4mm lateral; 9.2mm deep;
n=3)37, anterior olfactory nucleus (+3.2; +1.5; −8; n=2), piriform cortex (+0.7; +4; −8; n=4)
or olfactory tubercle (+2.7; +2; −8; n=2) over 20min. One week later, rats were perfused
transcardially with 4% paraformaldehyde and brains processed for immunohistochemistry.
Electrophysiology
For in vitro electrophysiology, glass microelectrodes (8–12MΩ) were filled with (mM): K-
gluconate 134, MgCl2 4, HEPES 10, Mg2ATP 3 Tris-GTP 0.3 NaCl 4, and EGTA 0.2
(pH7.3 adjusted with KOH, 270mOsm). In urethane-anaesthetised Sprague-Dawley rats
(250-300g), extracellular recordings were made using glass microelectrodes filled with
0.9%NaCl (tip diameter ~1μm). Recordings were made from single mitral cells in the main
olfactory bulb (~7mm anterior to bregma, ~1.3mm lateral) identified antidromically
(collision test) by electrical stimulation of the ipsilateral lateral olfactory tract21 (1.4mm
posterior to bregma, 3.2mm lateral, 9.5mm deep, latencies in range 1.0-5.8ms)37. Activity
quotients (proportion of time active relative to total time) were calculated, and the hazard
function (5-ms bins; hazard in bin [t, t+5])=(number of intervals in bin [t, t+5])/number of
intervals of length > t) plotted38. Odours were applied via a polythene cannula (0.1mm
diameter) placed 3mm in front of the nose. Cells were tested with a range of odours
including heptanal, hexanal, lemon and peppermint, using a 1-ml syringe filled with odour-
saturated air; 0.1ml air was ejected over 2s for each test; clean air had no effect.
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Data were analysed by ANOVA followed by Fisher's least significant difference test for
planned comparisons, Mann-Whitney U-test or unpaired Student's t-tests. P <0.05 was
considered significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Vasopressin neurons in the olfactory bulb
a, Most vasopressin cells in eGFP transgenic rats (DAB staining) are in the periglomerular
region throughout the main olfactory bulb. b, An apical dendrite ramifies into a glomerulus
(blue staining, periglumerular cell marker calbindin 28K). Confirmation using antibodies
against (c) GFP and (d) vasopressin in transgenic rats and (e) vasopressin in wild-type rats.
f, in situ hybridisation for vasopressin mRNA. g-i, Vasopressin cells do not co-express
calbindin, calretinin or GABA (red), but (j-l) contain glutamate. m-o, FluoroGold labelling
after injection into the anterior olfactory nucleus in mitral and periglomerular cells, but not
vasopressin cells. V1a receptors are expressed on (p) mitral cells and many periglomerular
neurones, but not on (q) vasopressin cells, whereas some vasopressin cells express V1b
receptors (r). s, Patch-clamp recording indicate firing patterns (spontaneous and
depolarized) like those of ET cells10. GCL granule cell layer, MCL mitral cell layer, EPL
epiform plexus layer, GL glomerular layer. Scale bars 20μm.
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Figure 2. Effects of V1a receptor blockade and vasopressin cell destruction on social recognition
a, A juvenile (J) is presented to an adult male (A) for 4min. This juvenile is removed and
after 30 or 180min is re-presented together with a non-familiar juvenile, and the preference
index calculated. b, administration of V1 antagonist results in performance similar to that
after extinction of short-term discrimination (after 180min). c, V1a receptor siRNA similarly
impairs discrimination after 4, 8 and 16 days of treatment. d, Selective destruction of
vasopressin cells via diphtheria toxin injection results in a similar impairment of
discrimination in transgenic rats, but not in wild-type rats. Means+S.E.M., * P<0.05 and **
P<0.001 vs control; numbers in columns are n/group.
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Figure 3. Specificity of effects on social recognition
a, Control rats and siRNA-treated rats showed similar habituation and dishabituation to
volatile scents. b, Control rats also showed habituation and dishabituation to juveniles,
siRNA-treated rats showed neither. c, Neither siRNA nor diphtheria toxin injection affected
object recognition (c). Means+S.E.M., * P<0.05 vs trial 4 and same treatment; numbers in
columns are n/group.
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Figure 4. Vasopressin effects on mitral cells
Effects of (a) vasopressin and (b) V1 antagonist on firing rate (a) and instantaneous
frequency in a single, representative mitral cell (a,b). The inset in a shows raw waveform
traces of spike activity. c, Vasopressin reduced the activity quotient in 6 cells treated with
4ng and 7 treated with 40ng vasopressin, and increased it in 7 cells treated with antagonist
(d) the hazard function overlay shows the reduction in doublet firing in a typical cell (light
line before, heavy line after vasopressin) (e) change in number of doublets (intervals<10ms);
quantified for all doublet cells f, top; spike activity in a mitral cell, showing activity
modulated by respiratory rhythm 5s before and after odour; below, cumulative spikes from
four tests during bursts before (above) and after (below) vasopressin. g, number of spikes 5s
before and 5s after odour for the tests in (f). h, responses of another cell to odour (arrows)
before, during and after aCSF and vasopressin. i, expanded instantaneous frequency records
of the cell shown in (h). j, Mean odour response in 16 cells tested with vasopressin, 7 of
which were also tested with aCSF, and in 10 of which recordings were maintained long
enough to observe recovery. Means+S.E.M. *P<0.05.
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